According to AIM ImmunoTech 's latest financial reports the company's current revenue (TTM ) is $0.17 Million USD. In 2022 the company made a revenue of $0.14 Million USD an increase over the revenue in the year 2021 that were of $0.13 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.